AZZONI, Cinzia
 Distribuzione geografica
Continente #
NA - Nord America 3.444
AS - Asia 2.873
EU - Europa 1.933
SA - Sud America 373
AF - Africa 171
Continente sconosciuto - Info sul continente non disponibili 81
OC - Oceania 7
Totale 8.882
Nazione #
US - Stati Uniti d'America 3.327
SG - Singapore 943
CN - Cina 822
VN - Vietnam 469
IT - Italia 400
IE - Irlanda 319
BR - Brasile 275
SE - Svezia 265
FI - Finlandia 243
HK - Hong Kong 202
DE - Germania 156
BD - Bangladesh 149
ZA - Sudafrica 115
UA - Ucraina 109
FR - Francia 96
CA - Canada 73
GB - Regno Unito 73
NL - Olanda 71
TR - Turchia 69
AT - Austria 50
IN - India 50
RU - Federazione Russa 47
AR - Argentina 41
BE - Belgio 25
IQ - Iraq 23
PL - Polonia 20
MX - Messico 19
JP - Giappone 17
PH - Filippine 17
EC - Ecuador 16
PK - Pakistan 16
MA - Marocco 15
ES - Italia 14
ID - Indonesia 12
CO - Colombia 11
UZ - Uzbekistan 11
CI - Costa d'Avorio 10
GR - Grecia 10
CZ - Repubblica Ceca 9
KR - Corea 8
LT - Lituania 8
CL - Cile 7
PE - Perù 7
VE - Venezuela 7
AU - Australia 6
IR - Iran 6
KE - Kenya 6
TW - Taiwan 6
DZ - Algeria 5
ET - Etiopia 5
JO - Giordania 5
OM - Oman 5
TH - Thailandia 5
BO - Bolivia 4
CY - Cipro 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
IL - Israele 4
MY - Malesia 4
PA - Panama 4
BH - Bahrain 3
DK - Danimarca 3
EG - Egitto 3
GE - Georgia 3
HN - Honduras 3
HU - Ungheria 3
JM - Giamaica 3
KZ - Kazakistan 3
NP - Nepal 3
PY - Paraguay 3
SA - Arabia Saudita 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CG - Congo 2
CR - Costa Rica 2
EE - Estonia 2
HR - Croazia 2
PT - Portogallo 2
SC - Seychelles 2
SV - El Salvador 2
AM - Armenia 1
GY - Guiana 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RO - Romania 1
SN - Senegal 1
TT - Trinidad e Tobago 1
Totale 8.800
Città #
Singapore 555
Ashburn 478
Chandler 357
Dublin 319
San Jose 294
Santa Clara 212
Hong Kong 189
Beijing 162
Dallas 159
Ho Chi Minh City 148
Hanoi 112
Los Angeles 112
Jacksonville 110
New York 108
Council Bluffs 107
Johannesburg 106
Dearborn 105
Boardman 102
Parma 100
Ann Arbor 92
Shanghai 81
Nanjing 73
Lauterbourg 55
Princeton 48
Vienna 47
Izmir 44
Munich 40
Hefei 38
Jinan 37
Helsinki 34
São Paulo 33
Turku 30
Wilmington 30
Shenyang 28
Toronto 28
San Mateo 27
Tianjin 25
Buffalo 23
Chicago 23
Da Nang 23
Seattle 22
Bologna 21
Moscow 21
Columbus 19
Nanchang 19
Bremen 18
Brussels 18
Changsha 17
Hebei 17
Montreal 17
Marseille 16
Tokyo 16
Warsaw 16
Woodbridge 16
London 15
Milan 15
Rome 15
Guangzhou 14
Kunming 14
Pune 14
Atlanta 13
Frankfurt am Main 13
Haiphong 13
Ankara 12
Baghdad 12
Denver 12
Des Moines 12
Nuremberg 12
Rio de Janeiro 12
San Francisco 12
Hangzhou 11
Abidjan 10
Brooklyn 10
Phoenix 10
The Dalles 10
Athens 9
Biên Hòa 9
Manchester 9
Poplar 9
Redondo Beach 9
Stockholm 9
Tashkent 9
Haikou 8
Modena 8
Naples 8
Rio Saliceto 8
Taiyuan 8
Zhengzhou 8
Amsterdam 7
Chennai 7
Fidenza 7
Hải Dương 7
Jakarta 7
Ningbo 7
Orem 7
Ottawa 7
Paris 7
Castrezzato 6
Charlotte 6
City of London 6
Totale 5.400
Nome #
ANASTOMOTIC RECURRENCE OF COLON CANCER: GENETIC ANALYSIS CHALLANGES THE WIDELY HELD THEORIES OF CANCEROUS CELLS’ INTRALUMINAL IMPLANTATION AND METACHRONOUS CARCINOGENESIS 212
Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab 208
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer 203
Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology? 199
Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors 198
Genetics of Darier’s Disease: New Insights into Pathogenic Mechanisms 190
Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method 186
Histological subtype analysis of colon cancer: a population-based study. Different sides and different diseases. 182
Impact of laterality and mucinous histology on relapse-free and overall survival in a registry-based colon cancer series 181
Human Papilloma Virus (HPV) status, P16INK4a and p53 overexpression in epithelial malignant and borderline ovarian neoplasms 177
P-027Cancer stem cells marker CD44 and Notch activation predict unfavorable prognosis in metastatic colon cancer patients treated with anti VEGF-therapy 175
Notch expression and bevacizumab efficacy in colorectal cancer patients 172
Cancer stem cells related marker CD44 and Notch activation in metastatic colon cancer patients 172
Microsatellite instability in colorectal cancer 172
Emergence of a HER2-amplified clone during disease progression in an ALK-rearranged NSCLC patient treated with ALK-inhibitors: A case report 170
Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies 168
Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancer 167
Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract 164
From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC 164
REPEATED ANASTOMOTIC RECURRENCE OF COLORECTAL TUMORS. GENETIC ANALYSIS OF TWO CASES. 162
Classification of gastric endocrine cells at the light and electron microscopical levels 161
ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis 159
Effect of chronic hypergastrinemia on human enterochromaffin-like cells: Insights from patients with sporadic gastrinomas 158
Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. 154
Different patterns of 11q allelic losses in digestive endocrine tumors 154
Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1. 153
Atrophic body gastriris patients with enterochromaffin-like cell dysplasia are at increased risk for development of type I gastric carcinoid 152
Adenomatous polyposis coli gene involvement in ileal enterochromaffin cell neuroendocrine neoplasms. 152
Notch Activation Modulates Bevacizumab Activity by CD44 Positive Cancer Stem Cells in Advanced Colon Cancer 152
p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior 149
The antral mucosa as a new site for endocrine tumors in Multiple Endocrine Neoplasia type-1 and Zollinger Ellison syndromes 149
Pancreatic Polypeptide-related tumors 149
Malignancy-associated allelic losses on X chromosome in foregut but not in midgut endocrine tumours 149
Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR-Mutated NSCLC 148
Primary Squamous Cell Carcinoma of the Endometrium Unrelated to Human Papilloma Virus: A Molecular Study 148
Reliability of EGFR and KRAS mutation analysis on fine-needle aspiration washing in non-small cell lung cancer 147
Pleomorph poorly differentiated endocrine carcinoma of the rectum 143
Monitoring cfDNA in plasma and in other liquid biopsies of advanced EGFR mutated NSCLC patients: A pilot study and a review of the literature 143
Metaplastic papillary tumour of the salpinx: report of a case with microsatellite analysis 142
Potential predictive biomarkers in locally advanced rectal cancer treated with preoperative chemo-radiotherapy 134
Optimizing PD-L1 evaluation on cytological samples from advanced non-small-cell lung cancer 133
YES1 and MYC Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical Proofs 132
ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin 130
REPEATED ANASTOMOTIC RECURRENCE OF COLORECTAL TUMORS. GENETIC ANALYSIS OF TWO CASES. 129
Sporadic colorectal carcinomas with low-level microsatellite instability: a distinct subgroup with specific clinicopathological and molecular features. 126
Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features 123
P16INK4a overexpression independent of Human Papilloma Virus (HPV) infection in rare subtypes of endometrial carcinomas 115
Prognostic immunoinflammatory and transcriptomic profiles in patients with pleural mesothelioma undergoing immunotherapy 113
Thymidylate synthase, topoisomerase-1 and microsatellite instability: relationship with outcome in mucinous colorectal cancer treated with fluorouracil. 113
Surgical treatment of multiple sporadic colorectal carcinoma 112
MET alterations as resistance mechanisms of dabrafenib-trametinib in BRAF p.V600E mutated non-small cell lung cancer patient 111
Influence of preoperative chemoradiation on tumor-infiltrating lymphocytes in locally advanced rectal cancer: The STAR-01 cohort 106
Intramucosal cysts in the gastric body of patients with Zollinger-Ellison syndrome 103
Progression of gastric enterochromaffin-like cells growth in Zollinger-Ellison syndrome and atrophic body gastritis patients 102
Therapeutic Outcomes and Clinical Features of Advanced Non-Small Cell Lung Cancer Carrying KRAS Mutations: A Multicenter Real-life Retrospective Study 99
Influence of preoperative chemoradiation on tumor-infiltrating lymphocytes in locally advanced rectal cancer: The STAR-01 cohort 96
BRAF Fusion as Resistance Mechanism to Osimertinib in EGFR-Mutated NSCLC: A Case Report and Review of Literature 95
Impact of preoperative chemoradiotherapy on tumor infiltrating lymphocytes in locally advanced rectal cancer: The SMART-STAR study 95
Sampling strategies for analysis of enterochromaffin-like (ECL) cell changes in Zollinger-Ellison syndrome 82
Multicenter Observational Study on Metastatic Non-Small Cell Lung Cancer Harboring BRAF Mutations: Focus on Clinical Characteristics and Treatment Outcome of V600E and Non-V600E Subgroups 72
Multiple targets, germline BRCA1 mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making 58
The Pathogenesis of the Neurofibroma-to-Sarcoma Transition in Neurofibromatosis Type I: From Molecular Profiles to Diagnostic Applications 19
Totale 8.882
Categoria #
all - tutte 30.701
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.701


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022273 0 1 4 18 13 8 42 24 16 17 34 96
2022/20231.232 106 155 66 96 101 146 12 85 393 14 43 15
2023/2024435 27 29 9 7 30 121 42 41 17 24 25 63
2024/20251.433 36 65 97 104 175 182 74 50 162 108 119 261
2025/20263.885 335 248 414 460 565 246 348 140 533 261 206 129
2026/2027209 105 104 0 0 0 0 0 0 0 0 0 0
Totale 8.882